Amniocentesis refers to amniocentesis, if the pregnant woman NT2.6 non-invasive low risk, no other high-risk factors generally do not need to do amniocentesis, if it is the advanced maternal age or have a poor maternal history need to do amniocentesis, according to their own situation to be evaluated.
Non-invasive (NT) is a prenatal screening method that screens for the risk of fetal chromosomal aneuploidy by taking peripheral blood of pregnant women and extracting free fetal DNA from it.
NT is the thickness of the fetal posterior nuchal translucency and 2.6 is the normal range. If the pregnant woman has no other high-risk factors, it means that the probability of the fetus suffering from chromosomal aneuploidy disorders is low, and amniocentesis is usually not needed.
Amniocentesis refers to obtaining amniotic fluid through amniocentesis for examination to find out whether the fetus has chromosomal abnormalities diseases, monogenic genetic diseases, etc. Amniocentesis is recommended if the pregnancy is of advanced age, or if there is a history of poor pregnancy and delivery or a family history of genetic diseases, etc., even if the pregnant woman is at low risk for non-invasive DNA.
During pregnancy, it is recommended to have regular and proper maternity checkups, and any abnormality can be promptly and actively handled under the guidance of specialists.